Skip to main content
Log in

Contrast-enhanced ultrasound of the small bowel in Crohn’s disease

  • Published:
Abdominal Imaging Aims and scope

Abstract

Crohn’s disease (CD) is a chronic transmural inflammatory disease of the gastrointestinal tract characterized by episodes of inflammation alternating with periods of remission. Unenhanced grey-scale ultrasound may evaluate the localisation and the length of the affected intestinal segments and may detect transmural complications, including fistulas, abscesses and phlegmons, but it is less accurate to assess the CD activity. Contrast-enhanced ultrasound has become an important imaging modality in patients with CD for the grading of disease activity, the differentiation between small bowel stricture due to inflammation or mural fibrosis, and for the assessment of the response to specific therapy. New dedicated software packages allow the accurate quantification of the enhancement within the small bowel wall after microbubble contrast agent injection to obtain different kinetic semi-quantitative parameters—the percentage of the maximal enhancement, the time-to-the peak enhancement, and the area under the time–intensity curve—which are very useful to differentiate the inflammatory oedema from fibrosis and to differentiate responders from non-responders to the specific therapy among patients with CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Quinn PG, Binion DG, Connors PJ (2001) Radiologic and endoscopic diagnosis of Crohn’s disease. Surg Clin North Am 81:39–70

    Article  Google Scholar 

  2. Paulsen SR, Huprich JE, Fletcher JG, et al. (2006) CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. RadioGraphics 26:641–657

    Article  PubMed  Google Scholar 

  3. Bodily KD, Fletcher JG, Solem CA, et al. (2006) Crohn’s disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 238:505–516

    Article  PubMed  Google Scholar 

  4. Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn’s disease. RadioGraphics 30:367–384

    Article  PubMed  Google Scholar 

  5. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14:1017–1024

    Article  PubMed  Google Scholar 

  6. Sempere GAJ, Martinez Sanjuan V, Medina Chulia E, et al. (2005) MRI evaluation of inflammatory activity in Crohn’s disease. Am J Roentgenol 184:1829–1835

    Article  Google Scholar 

  7. Martínez MJ, Ripollés T, Paredes JM, Blanc E, Martí-Bonmatí L (2009) Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI. Abdom Imaging 34:141–148

    Article  PubMed  Google Scholar 

  8. Leyendecker JR, Bloomfeld RS, DiSantis DJ, et al. (2009) MR enterography in the management of patients with Crohn’s disease. Radiographics 29:1827–1846

    Article  PubMed  Google Scholar 

  9. Ripollés T, Martínez-Pérez MJ, Blanc E, et al. (2011) Contrast-enhanced ultrasound (CEUS) in Crohn’s disease: technique, image interpretation and clinical applications. Insights Imaging 2:639–652

    Article  PubMed  Google Scholar 

  10. Quaia E (2007) Microbubble ultrasound contrast agents: an update. Eur Radiol 17:1995–2008

    Article  PubMed  Google Scholar 

  11. Piscaglia F, Nolsøe C, Dietrich CF, et al. (2012) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall in Med 33:33–59

    Article  CAS  Google Scholar 

  12. De Franco A, Di Veronica A, Armuzzi A, et al. (2012) Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. Radiology 262:680–688

    Article  PubMed  Google Scholar 

  13. Wong DD, Forbes GM, Zelesco M, et al. (2012) Crohn’s disease activity: quantitative contrast-enhanced ultrasound assessment. Abdom Imaging 37:369–376

    Article  PubMed  Google Scholar 

  14. Rimola J, Ordás I, Rodríguez S, Ricart E, Panés J (2012) Imaging indexes of activity and severity for Crohn’s disease: current status and future trends. Abdom Imaging 37:958–966

    Article  PubMed  Google Scholar 

  15. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. Gastroenterology 70:439–444

    PubMed  CAS  Google Scholar 

  16. Quinn PG, Binion DG, Connors PJ (2001) Radiologic and endoscopic diagnosis of Crohn’s disease. Surg Clin North Am 81:39–70

    Article  Google Scholar 

  17. Pauls S, Gabelmann A, Schmidt SA, et al. (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound. Eur Radiol 16:2410–2417

    Article  PubMed  Google Scholar 

  18. Ripollés T, Martínez MJ, Paredes JM, et al. (2009) Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 253:241–248

    Article  PubMed  Google Scholar 

  19. Migaleddu V, Quaia E, Scanu D, et al. (2011) Inflammatory activity in Crohn’s disease: CE-US. Abdom Imaging 36:142–148

    Article  PubMed  Google Scholar 

  20. De Franco A, Marzo M, Felice C, et al. (2012) Ileal Crohn’s disease: CEUS determination of activity. Abdom Imaging 37:359–368

    Article  PubMed  Google Scholar 

  21. Migaleddu V, Scanu AM, Quaia E, et al. (2009) Contrast-enhanced ultrasonography evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 137:43–61

    Article  PubMed  Google Scholar 

  22. Serra C, Menozzi G, Morselli AM, et al. (2007) Ultrasound assessment of vascularisation of the thickened terminal ileum wall in Crohn’s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 62:114–121

    Article  PubMed  Google Scholar 

  23. Bodily KD, Fletcher JG, Solem CA, et al. (2006) Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 238:505–516

    Article  PubMed  Google Scholar 

  24. Sempere GAJ, Martinez Sanjuan V, Medina Chulia E, et al. (2005) MRI evaluation of inflammatory activity in Crohn’s disease. Am J Roentgenol 184:1829–1835

    Article  Google Scholar 

  25. Martínez MJ, Ripollés T, Paredes JM, Blanc E, Martí-Bonmatí L (2009) Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI. Abdom Imaging 34:141–148

    Article  PubMed  Google Scholar 

  26. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 14(6):1017–1024

    Article  PubMed  Google Scholar 

  27. Maconi G, Bollani S, Bianchi Porro G (1996) Ultrasonographic detection of intestinal complications in Crohn’s disease. Dig Dis Sci 41:1643–1648

    Article  PubMed  CAS  Google Scholar 

  28. Schirin-Sokhan R, Winograd R, Tischendorf S, et al. (2011) Assessment of inflammatory and fibrotic stenoses in patients with Crohn’s disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study. Digestion 83:263–268

    Article  PubMed  Google Scholar 

  29. Ripollés T, Rausell N, et al. (2013) Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohn’s Colitis 7:120–128

    Article  Google Scholar 

  30. Quaia E, De Paoli L, Stocca T, et al. (2012) The value of small bowel wall contrast enhancement after sulphur hexafluoride-filled microbubble injection to differentiate Inflammatory from fibrotic strictures in patients with Crohn’s disease. Ultrasound Med Biol 38:1324–1332

    Article  PubMed  Google Scholar 

  31. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W (2006) American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130:935–939

    Article  PubMed  Google Scholar 

  32. Giangregorio F, Bertone A, et al. (2009) Predictive value of time–intensity obtained with contrast enhanced ultrasonography (CEUS) in the follow-up of 30 patients with Crohn’s disease. J Ultrasound 12:151–159

    Article  PubMed  CAS  Google Scholar 

  33. Quaia E, Cabibbo B, De Paoli L, Toscano W, Poillucci G, Cova MA (2013) The value of time–intensity curves obtained after microbubble contrast agent injection to discriminate responders from non responders to anti-inflammatory medication among patients with Crohn’s disease. Eur Radiol 23:1650–1659

    Article  PubMed  Google Scholar 

  34. Guidi L, De Franco A, De Vitis I, et al. (2006) Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn’s disease. Eur Rev Med Pharmacol Sci 10:23–26

    PubMed  CAS  Google Scholar 

  35. Quaia E, Migaleddu V, Baratella E, et al. (2009) The diagnostic value of small bowel wall vascularity after sulphur hexafluroride-filled microbubble injection in patients with Crohn’s disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. Eur J Radiol 69:438–444

    Article  PubMed  Google Scholar 

  36. Di Sabatino A, Fulle I, Ciccocioppo R, et al. (2002) Doppler enhancement after intravenous levovist injection in Crohn’s disease. Inflamm Bowel Dis 8(4):251–257

    Article  PubMed  Google Scholar 

  37. Rapaccini GL, Pompili M, Orefice R, et al. (2004) Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 39:188–194

    Article  PubMed  CAS  Google Scholar 

  38. Robotti D, Cammarota T, Debani P, Sarno A, Astegiano M (2004) Activity of Crohn disease: value of color-power-Doppler and contrast-enhanced ultrasonography. Abdom Imaging 29:648–652

    Article  PubMed  CAS  Google Scholar 

  39. Onali S, Calabrese E, Petruzziello C, et al. (2010) Endoscopic vs ultrasonographic findings related to Crohn’s disease recurrence: a prospective longitudinal study at 3 years. J Crohns Colitis 4:319–328

    Article  PubMed  CAS  Google Scholar 

  40. Pallotta N, Giovannone M, Pezzotti P, et al. (2010) Ultrasonographic detection and assessment of the severity of Crohn’s disease recurrence after ileal resection. BMC Gastroenterol 10:69

    Article  PubMed  Google Scholar 

  41. Pallotta N, Vincoli G, Montesani C, et al. (2012) Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in Crohn’s disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis 18:74–84

    Article  PubMed  Google Scholar 

  42. Maconi G, Bianchi Porro G (2005) Intestinal pathology. In: Quaia E (ed) Contrast media in ultrasonography: basic principles and clinical applications. New York: Springer, pp 349–358

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emilio Quaia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quaia, E. Contrast-enhanced ultrasound of the small bowel in Crohn’s disease. Abdom Imaging 38, 1005–1013 (2013). https://doi.org/10.1007/s00261-013-0014-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-013-0014-8

Keywords

Navigation